表紙
市場調査レポート

欧州の子宮頸癌検査市場の分析

2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK

発行 Venture Planning Group 商品コード 273958
出版日 ページ情報 英文 240 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。

Local License: 同一事業所内

Back to Top
欧州の子宮頸癌検査市場の分析 2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK
出版日: ページ情報: 英文 240 Pages
概要

当レポートでは、欧州の主要国(フランス、ドイツ、イタリア、スペイン、英国)における子宮頸癌検査(Pap Smear/HPV)市場について調査分析し、5年間の検査件数と売上高予測(国別・市場セグメント別)を提供するほか、技術の概要、市場普及戦略、市場参入戦略などを概説し、主要企業プロファイルを提供して、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術の概要

  • 子宮頸癌検査(Pap Smear/HPV):臨床的意義と検査例
  • 現在/新興の技術
    • モノクローナル/ポリクローナル抗体
    • イムノアッセイ
    • 分子診断
    • 染色体分析
    • 人工知能
    • フローサイトメトリー
    • 2次元ゲル電気泳動(2-DGE)
    • バイオセンサー
    • 競合/補完技術
    • 個人検査

フランス:検査件数と売上高予測(市場セグメント別)

ドイツ:検査件数と売上高予測(市場セグメント別)

イタリア:検査件数と売上高予測(市場セグメント別)

スペイン:検査件数と売上高予測(市場セグメント別)

英国:検査件数と売上高予測(市場セグメント別)

分散型検査製品の設計基準

代替的な市場浸透戦略

  • 国内開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

癌診断製品サプライヤー

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Veridex
  • 和光純薬工業
  • Wallac/PE
  • Zila

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCA20700

Complete report $2,850.  DataPack (test volumes, sales forecasts) $1,850.

This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment.

The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Contains 240 pages and 16 tables

Table of Contents

I. Introduction

II. PAP Smear/HPV Worldwide Market and Technology Overview

  • A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
  • B. Instrumentation Review And Market Needs
    • 1. Abbott AxSYM
    • 2. Abbott Architect c4000
    • 3. Abbott Architect i2000 Series
    • 4. Abbott Architect ci8200 System
    • 5. Beckman Coulter UniCel Series
    • 6. Beckman Coulter Access
    • 7. Binding Site ESP600
    • 8. bioMerieux Mini Vidas
    • 9. Carolina Chemistries BioLis 24i
    • 10. DiaSorin Liaison
    • 11. Horiba ABX Pentra 400
    • 12. Inverness DS2
    • 13. J&J Vitros ECi/ECiQ
    • 14. J&J Vitros 3600
    • 15. J&J Vitros 5600
    • 16. Olympus AU5400
    • 17. Olympus AU3000i
    • 18. Olympus AU2700
    • 19. Roche Modular Analytics
    • 20. Roche Cobas Integra 400
    • 21. Roche Cobas Integra 400 Plus
    • 22. Roche Elecsys
    • 23. Roche Cobas c311
    • 24. Siemens ADVIA Centaur
    • 25. Siemens Dimension
    • 26. Siemens Dimension RxL Max
    • 27. Siemens Dimension Vista 500
    • 28. Siemens Immulite
    • 29. Siemens Stratus
    • 30. Tosoh AIA-Series
    • 31. Vital Diagnostics ATAC 8000
    • 32. Vital Diagnostics Envoy 500
  • C. Current and Emerging Technologies
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • b. Radioimmunoassay (RIA)
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • Immunofiltration
        • Particle-Membrane Capture Immunoassay
        • Enzyme Amplification
      • d. Fluorescent Immunoassays
      • e. Luminescence
        • Chemiluminescence
        • Bioluminescence
      • f. Latex Agglutination
      • g. Immunoprecipitation
        • H. Affinity Chromatographu
      • e. Liposome Flow-Injection Immunoassay
    • 3. Molecular Diagnostics
      • a. Technology Overview
      • b. Amplification Methods
        • PCR
        • DAP-PCR
        • Immuno-PCR
        • QC-PCR
        • CAR
        • DNA
        • HPA
        • LCR
        • NASBA
        • QBR
        • SDA
        • 3 SR, and others
    • 4. Chromosome Analysis
      • a. Chronic Myelogenous Leukemia (CML)
      • b. Acute Myeloid Leukemia (AML)
      • c. Acute Lymphoblastic Leukemia (ALL)
      • d. Malignant Lymphomas
        • Lymphoid Malignancies
      • e. Chronic Lymphocytic Leukemia (CLL)
      • f. Solid Cancers
      • g. Chromosomal Translocation and Oncogenes
    • 5. Artificial Intelligence
    • 6. Flow Cytometry
    • 7. Two Dimensional Gel Electrophoresis (2-DGE)
    • 8. Biosensors
    • 9. Competing/Complementing Technologies
      • a. CT
      • b. MRI
      • c. NMR
      • d. PET
      • e. Photonics Spectroscopy
  • D. Personal Testing

III. France: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VI. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VII. U.K.: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VIII. Design Criteria for Decentralized Testing Products

IX. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

X. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XI. Competitive Profiles

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics/Theradiag
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Elitech Group
  • Epigenomics
  • Enterix/Clinical Genomics
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Vermillion
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

List of Tables

  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • France, PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • France, Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
  • Germany, PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Germany, Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
  • Italy, PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Italy, Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
  • Spain, PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Spain, Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
  • U.K., PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • U.K., Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Back to Top